• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Cns Pharmaceuticals Inc (NQ: CNSP )

    0.1991 UNCHANGED
    Streaming Delayed Price Updated: 3:57 PM EDT, Apr 22, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 0
    Open -
    Bid (Size) 0.1950 (20)
    Ask (Size) 0.2300 (22)
    Prev. Close 0.1991
    Today's Range 0.1991 - 0.1991
    52wk Range 0.1900 - 2.980
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    BioMedNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Spotlighted in Upcoming Virtual Investor Lunch Break Event
    Via Investor Brand Network
    12 Health Care Stocks Moving In Monday's Pre-Market Session
    Via Benzinga

    Performance

    YTD
    -83.27%
    -83.27%
    1 Month
    -47.33%
    -47.33%
    3 Month
    -68.66%
    -68.66%
    6 Month
    -90.52%
    -90.52%
    1 Year
    -89.24%
    -89.24%

    More News

    Read More
    CNS Pharmaceuticals to Participate in the Virtual Investor Lunch Break: The CNSP Opportunity
    Via ACCESSWIRE
    BioMedNewsBreaks — CNS Pharmaceuticals Inc.’s (NASDAQ: CNSP) Berubicin Represents Opportunity to Provide Solution for GBM Patients
    Via Investor Brand Network
    New Research Sheds Light on the Initial Stages of Brain Cancer Development
    Via Investor Brand Network
    12 Health Care Stocks Moving In Friday's After-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Monday's Intraday Session
    Via Benzinga
    Researchers Link Hormone Treatments to Heightened Risk of Brain Tumors
    Via Investor Brand Network
    BioMedNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Releases FY 2023 Financial Report, Corporate Update
    Via Investor Brand Network
    CNSP Stock Earnings: CNS Pharmaceuticals Reported Results for Q4 2023
    Via InvestorPlace
    CNS Pharmaceuticals Reports Full Year 2023 Financial Results and Highlights Recent Corporate and Clinical Achievements
    Via ACCESSWIRE
    CNS Pharmaceuticals to Present at Two Investor Conferences in April
    Via ACCESSWIRE
    CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) Welcomes Proven Commercialization Leader to Its Board of Directors
    Via Investor Brand Network
    Study Shows Troops That Sustain Serious Brain Injuries Have Higher Risk of Brain Cancer
    Via Investor Brand Network
    Top 5 Health Care Stocks That Are Preparing To Pump In February
    Via Benzinga
    12 Health Care Stocks Moving In Wednesday's After-Market Session
    Via Benzinga
    Scientists Start Trialing First Blood Test Against Brain Cancer
    Via Investor Brand Network
    12 Health Care Stocks Moving In Tuesday's After-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Tuesday's Intraday Session
    Via Benzinga
    Why UPS Shares Are Trading Lower By 8%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
    Via Benzinga
    BioMedNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Releases Information on $4M Public Offering Pricing
    Via Investor Brand Network
    12 Health Care Stocks Moving In Tuesday's Pre-Market Session
    Via Benzinga
    Why Super Micro Computer Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket
    Via Benzinga
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
    Via InvestorPlace
    12 Health Care Stocks Moving In Monday's After-Market Session
    Via Benzinga
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.